Related Articles
NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition
NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
NIMA‑related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation
Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation
CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle